US · Healthcare

CSPC Pharmaceutical Group Limited (CSPCY)

Drug Manufacturers - General

CSPC Pharmaceutical Group Limited (CSPCY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CSPCY

P/E ratio

18.00

CSPC Pharmaceutical Group Limited (CSPCY) — FAQ

What is CSPCY's P/E ratio?

The price-to-earnings (P/E) ratio for CSPC Pharmaceutical Group Limited (CSPCY) is 18.00 (data as of 2026-03-24).

Does CSPC Pharmaceutical Group Limited pay a dividend?

Dividend yield is not available in the current snapshot for CSPC Pharmaceutical Group Limited (CSPCY). Check the MyAverix Finance app for the latest dividend data.

What sector is CSPC Pharmaceutical Group Limited in?

CSPC Pharmaceutical Group Limited (CSPCY) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is CSPCY listed on?

CSPCY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)